High Serum Advanced Glycation End Products Are Associated with Decreased Insulin Secretion in Patients with Type 2 Diabetes: A Brief Report

Table 3

Serum AGEs levels.

AGE
	CEL; (ng/mL)	CML; (ng/mL)	MG-H1; (ng/mL)
T2DM ()	15.4 ± 6.6	21.0 ± 7.0	27.2 ± 20.7
Non-DM ()	9.8 ± 2.2	15.1 ± 4.2	17.5 ± 8.2
value	<0.001	<0.01	NS

Data are mean ± standard deviation. AGEs: advanced glycation end products; CEL: carboxyethyllysine; CML: carboxymethyllysine; MG-H1: methyl-glyoxal-hydro-imidazolone; T2DM: study participants with type 2 diabetes mellitus; Non-DM: nondiabetic study participants; NS: not significant.